Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial.
The Lancet. Infectious Diseases
Hardt, Karin K; Vandebosch, An A; Sadoff, Jerald J; Le Gars, Mathieu M; Truyers, Carla C; Lowson, David D; Van Dromme, Ilse I; Vingerhoets, Johan J; Kamphuis, Tobias T; Scheper, Gert G; Ruiz-Guiñazú, Javier J; Faust, Saul N SN; Spinner, Christoph D CD; Schuitemaker, Hanneke H; Van Hoof, Johan J; Douoguih, Macaya M; Struyf, Frank F; ,
Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S.
The New England Journal Of Medicine
Sadoff, Jerald J; Gray, Glenda G; Vandebosch, An A; Cárdenas, Vicky V; Shukarev, Georgi G; Grinsztejn, Beatriz B; Goepfert, Paul A PA; Truyers, Carla C; Van Dromme, Ilse I; Spiessens, Bart B; Vingerhoets, Johan J; Custers, Jerome J; Scheper, Gert G; Robb, Merlin L ML; Treanor, John J; Ryser, Martin F MF; Barouch, Dan H DH; Swann, Edith E; Marovich, Mary A MA; Neuzil, Kathleen M KM; Corey, Lawrence L; Stoddard, Jeffrey J; Hardt, Karin K; Ruiz-Guiñazú, Javier J; Le Gars, Mathieu M; Schuitemaker, Hanneke H; Van Hoof, Johan J; Struyf, Frank F; Douoguih, Macaya M; ,